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Abstract
Background: This study tested a low-volume (20–30 µl/20–30 µg DNA) jet injection method for
intradermal delivery of a DNA vaccine. Jet injection offers the advantages of a needle-less system,
low-cost, rapid preparation of the injected DNA solution, and a simple delivery system. More than
one construct can be injected simultaneously and the method may be combined with adjuvants.
Results: Low-volume jet injection targeted delivery of a DNA solution exclusively to the dermis
and epidermis of rabbits. A three injection series of plasmid DNA, encoding the Hepatitis B Surface
Antigen stimulated a humoral immune response in 2/5 rabbits. One rabbit developed a significant
rise in antibody titer after 1 injection and one following 2 injections. There were no significant
differences between jet injection and particle bombardment in the maximal antibody titers or
number of injections before response. A three injection series of the same plasmid DNA by particle
bombardment elicited a significant rise in antibody titer in 3/5 rabbits. One rabbit developed
antibody after 1 injection and two after 3 injections. In contrast, 0/5 rabbits receiving DNA by
needle and syringe injection responded. In the jet injection and particle bombardment groups, gene
expression levels in the skin did not predict response. While immune responses were similar,
luciferase gene expression levels in the skin following particle bombardment were 10–100 times
higher than jet injection.
Conclusion: Low-volume jet injection is a simple, effective methodology for intradermal DNA
immunization.
Background
Jet injection is a relatively simple and low-cost method for
gene transfer into somatic tissues [1]. Aside from the injec-
tor, no special equipment or solutions are required. Plas-
mid DNA is suspended at the desired concentration in
one of several types of solution and injected into tissue.
More than one plasmid construct can be injected simulta-
neously. Injection of antigen encoding plasmids can be
combined with either adjuvants or plasmids encoding im-
mune enhancing cytokines. Low-volume jet injection de-
liberately limits the volume of the injected solution and is
utilized to target delivery to small tissue areas [2].
Published: 23 May 2002
BMC Biotechnology 2002, 2:10
Received: 13 December 2001
Accepted: 23 May 2002
This article is available from: http://www.biomedcentral.com/1472-6750/2/10
© 2002 Ren et al; licensee BioMed Central Ltd. Verbatim copying and redistribution of this article are permitted in any medium for any purpose, provided 
this notice is preserved along with the article's original URL.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/10
Page 2 of 6
(page number not for citation purposes)
In mice, multiple different routes of DNA immunization
have been used successfully [3]. Particle bombardment of
skin is reported to be superior to both intra-dermal and
intra-muscular needle and syringe injection for induction
of immunity in mice when compared directly [4–8]. In
Aotus monkeys and pigs, intra-dermal administration of
DNA vaccine by needle and syringe is reported to be more
effective at inducing an immune response than intra-mus-
cular administration by needle and syringe [9,10]. High-
volume jet injection (500 µl) of either 100 or 1000 µg
DNA into ovine muscle or mammary gland [11,12] or
500 µg DNA into four separate muscle sites in rabbits [13]
induces humoral immunity.
Multiple studies have demonstrated that particle bom-
bardment of skin elicits immune responses in larger ani-
mals [14–18]. Similarly, high-volume jet injection (100
µl) of either 50 or 250 µg DNA into the skin of primates
induces immunity [19]. Delivery to the oral mucosa by jet
injection elicited a higher IgA response than intranasal de-
livery in mice [20]. However, none of these studies com-
pared different intracutaneous DNA delivery methods
within the same study.
This investigation tested the ability of low-volume jet in-
jection to target delivery of a DNA vaccine to the skin for
the purpose of inducing immunity. A direct comparison
of the new methodology to the established techniques of
particle bombardment and needle and syringe injection
was performed. The experiments demonstrated that low-
volume jet injection successfully induced immunity in
rabbits. Moreover, there were no significant differences
between jet injection and particle bombardment in the
maximal antibody titers or number of injections before re-
sponse. In contrast no rabbits receiving DNA vaccine by
needle and syringe injection developed an antibody re-
sponse. In the low-volume jet injection and particle bom-
bardment groups, gene expression levels in the skin did
not predict the magnitude of the immune response. While
immune responses were comparable, luciferase gene ex-
pression levels in the skin following particle bombard-
ment were 10–100 times higher than low-volume jet
injection.
Results and discussion
Low-volume jet injection targets delivery of a plasmid DNA 
solution to the epidermis and dermis of rabbits
Injection path lengths were measured following low-vol-
ume jet injection of a 1% India ink solution. Injection
paths averaged between 0.5 mm and 0.75 mm (Figure 1).
The injection paths did not extend through the dermis.
These experiments show that low-volume jet injection
specifically targeted delivery of a DNA solution to the skin
and that the injection paths did not reach into the under-
lying tissue.
Optimal injection parameters for low-volume jet injection, 
particle bombardment and needle and syringe injection
Optimal injection parameters for each technique were es-
tablished by comparing relative mean expression levels of
the luciferase reporter gene in the skin 48 hours after in-
jection. Injection parameters that yielded the highest lev-
els of luciferase expression were selected as optimal.
Particle bombardment produced the highest mean levels
of luciferase activity (Table 1). Mean luciferase activity fol-
lowing low-volume jet injection was 10–100 fold lower
than following particle bombardment. Mean luciferase
activity following needle and syringe injection was 50 fold
lower than jet injection.
Figure 1
Penetration depth of low-volume jet injection into rabbit
skin. The injection paths of three separate low-volume jet
injections of a 1% India ink solution at 3 Bar into rabbit skin
are illustrated in panels A (1 path) and B (2 paths). Penetra-
tion depths averaged between 0.5 mm and 0.75 mm. Arrows
indicate injection points into the epidermis.
A
0.5mm
 B
0.5mm
Table 1: Mean relative luciferase activity in skin 48 hours following 
low-volume jet, particle bombardment, and needle and syringe 
injection.
Injection method Mean relative luciferase 
units ± SE
n
Low-volume jet 314.3 ± 112 5
Particle bombardment 17,023 ± 7077 2
Needle and syringe 1.8 ± 0.62 10
SE: Standard error.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/10
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Maximal antibody titers and number of injections before 
response following low-volume jet injection, particle bom-
bardment, and needle and syringe delivery of a DNA vac-
cine to the skin
Injections of plasmid DNA encoding the Hepatitis B Sur-
face Antigen (HBSAg) were performed at Days 0, 14 and
28. Antibody titers were determined prior to any injection
(Day 0), two weeks after each of the three injections (Days
14, 28, and 42), and four weeks after the third and final
injection (Day 56). By days 14 and 28 two of five rabbits
immunized by low-volume jet injection demonstrated a
statistically significant and titratable response at serial
time points that persisted through day 56 (Figure 2A)
(ANOVA, P = 0.009 at the 1:250 dilution; P = 0.003 at the
1:2,500 dilution at day 56). The number of injections be-
fore response and the maximal antibody responses were
comparable to rabbits that received DNA immunization
by particle bombardment. By days 14 (1) and 42 (2) three
of five rabbits immunized by particle bombardment dem-
onstrated a statistically significant response at serial time
points (Figure 2B). One rabbit expired during anesthesia
at the day 28-injection time point. At day 56 the immune
response was statistically significant only at the 1:250 di-
lution in the two remaining rabbits (ANOVA, P < 0.001 at
the 1:250 dilution; P = 0.609 at the 1:2,500 dilution).
There was no statistically significant difference in maximal
antibody titers between low-volume jet injection and par-
ticle bombardment (ANOVA, P = 0.875) (Figure 3). In
contrast to immunization with either low-volume jet or
particle bombardment, there was no significant titratable
antibody response in rabbits that received DNA immuni-
zation by needle and syringe injection (ANOVA, P = 0.062
Figure 2
Development of antibody response following low-volume jet
injection and particle bombardment. Injections performed at
days 0, 14 and 28. Serum drawn prior to each injection and at
days 42 and 56. Data presented for individual rabbits. Five
rabbits (Rabbits 1–5) received DNA immunization by low-
volume jet injection and five rabbits (Rabbits 6–10) received
DNA immunization by particle bombardment. Antibody
detected by ELISA and presented as optical density (O.D.).
Serum dilution 1:250. A. Low volume jet injection. Statisti-
cally significant rises in antibody titer were detected at four
serial time points in Rabbit 1 (light gray squares; ANOVA, P
= 0.005) and three serial time points in Rabbit 2 (black
squares; ANOVA, P < 0.001) as compared to negative con-
trol sera. B. Particle bombardment injection. Statistically sig-
nificant rises in antibody titer were detected at two serial
time points in Rabbit 6 (black squares; ANOVA, P < 0.001),
Rabbit 7 (light gray squares; ANOVA, P < 0.001), and Rabbit
8 (medium gray squares; ANOVA, P 0 = 0.003) as compared
to negative control sera. Rabbit 6 expired during anesthesia
after the day 28 injection.
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Figure 3
Comparison of maximal antibody titers following low-volume
jet injection (0.35 ± 0.13) and particle bombardment (0.33 ±
.05) at a 1:250 serum dilution. Maximal antibody titers are
defined as the highest antibody titer that was measured in
each individual rabbit. Mean ± S.E is shown. There was no sig-
nificant difference in maximal antibody titers between the
two methods (ANOVA, P = 0.875).
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at the 1:250 dilution; P = 0.140 at the 1:2,500 dilution at
day 56). Longer-term experiments and larger groups of
rabbits will be required to determine if persistence of an-
tibody is different between the low-volume jet injected
and particle bombardment groups.
The experiments demonstrate that intradermal low-vol-
ume jet injection of a DNA vaccine can be utilized to elicit
immune responses. The low-volume jet injection method
was comparable to the more established technique of par-
ticle bombardment and was significantly better than the
established technique of needle and syringe injection.
Conclusion
Low-volume jet injection is an effective new methodology
for intradermal DNA immunization that has advantages
over the established techniques of needle and syringe in-
jection and particle bombardment. It is more effective
than needle and syringe injection and is simpler to per-
form than particle bombardment because the plasmid
DNA solution can be injected directly rather than being
precipitated onto specific particles. High levels of gene ex-
pression were not required for successful intradermal ge-
netic immunization by low-volume jet injection. Gene
expression levels following particle bombardment were
10–100 fold higher than those found following low-vol-
ume jet injection but the immune response was equiva-
lent. The disassociation between local gene expression
levels in the injected skin and immune response is consist-
ent with a previous report [16].
Materials and methods
Plasmids
A plasmid encoding the HBSAg under the control of the
Human Cytomegalovirus Immediate Early gene I
(HCMVIE1) enhancer/promoter (pRc/CMV-HBs(S) was
obtained from Aldevron (Fargo, ND) [20]. A plasmid en-
coding the firefly luciferase gene under the control of the
HCMVIE1 enhancer/promoter (pHCMVIE1-luciferase)
was used to measure relative gene expression levels fol-
lowing gene transfer by low-volume jet injection, particle
bombardment and needle and syringe injection [2]. Plas-
mids were propagated in DH5α  cells and purified by Bio
101 Merlin Core Services (Carlsbad, CA).
Animals, skin preparation, and injection schedules
Twenty-five male New Zealand White rabbits were ob-
tained at 2–3 kg in weight. Animals were purchased from
a commercial vendor (Covance, Denver, PA). Health sta-
tus was evaluated quarterly by the vendor and the animals
were free of tested pathogens (other than Bordetella bron-
chiseptica and rotavirus but these were not expected to in-
terfere with the current study). The rabbits were in
excellent health and not symptomatic. The rabbits were
anesthetized with 40 mg/kg Ketamine (100 mg/ml,) and
3 mg/kg Xylazine (20 mg/ml) prior to each injection. In
preparation for injection, the dorsal skin was shaved,
treated with a depilatory, and washed with a chlorhexi-
dine scrub followed by 70% alcohol. Following injections
0.05 mg/kg Buprenorphine (0.3 mg/ml) was given for an-
algesia.
To establish skin penetration depth following low-vol-
ume jet injection, one rabbit was injected at 6 different
sites with a 1% India ink solution. The skin was removed
at necropsy and examined under a dissecting microscope
to measure the length of the injection paths. To establish
optimal injection conditions for low-volume jet injection,
two rabbits were injected at a total of 15 sites per rabbit
with pHCMVIE1-luciferase and euthanized 48 h later. The
injected skin was removed at necropsy and tested for luci-
ferase activity. When using particle bombardment the
goal is to deliver the majority of gold particles into the ep-
ithelial cell layer rather than the deeper, less cellular der-
mis [21]. To establish skin penetration depth following
particle bombardment, four rabbits were injected at eight
sites on each rabbit. The skin was removed at necropsy
and fixed in 10% neutral formalin, embedded by standard
methods, and 5-micron sections were prepared. Hematox-
ylin and eosin stained sections were examined under the
microscope to determine the penetration depth. Gold par-
ticles were found distributed primarily in the epidermis
and minimally in the superficial dermis of the rabbit skin
(data not shown). To establish optimal injection condi-
tions for particle bombardment, six rabbits were injected
at a total of 12 sites per rabbit with pHCMVIE1-luciferase
and euthanized 48 h later. The injected skin was removed
at necropsy and tested for luciferase activity. To establish
optimal conditions for intra-dermal needle and syringe
injection, two rabbits were injected at a total of 7 sites per
rabbit with pHCMVIE1-luciferase and euthanized 48 h
later. The injected skin was removed at necropsy and test-
ed for luciferase activity.
For the immunization experiments, rabbits were injected
at three time points at two weeks intervals: 0 days, 14 days
and 28 days. Three ml blood was obtained from an ear
vein prior to each injection and two weeks and four weeks
following the third and final injection. One of the five rab-
bits that received particle bombardment injection died
under anesthesia prior to the second injection. A necropsy
was performed, no abnormalities were found, and the
death was attributed to anesthesia.
Optimization of low-volume jet injection, particle bom-
bardment and needle and syringe injection conditions
Low-volume jet injection was performed with a prototype
low-volume jet injector with adjustable injection volume
and pressure. The plasmid DNA solution at 1 µg/µl was
prepared in phosphate buffered saline (PBS). The injectorBMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/10
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is manufactured with a refillable liquid reservoir that
holds 180 µl and can rapidly deliver multiple injections to
the same site (EMS, Konstanz, Germany) [2,22]. For opti-
mization of the jet injection experiments, three different
injection volume settings (5-µl, 6-µl and 7-µl) at three dif-
ferent pressures (1,2 and 3-Bar) were tested. When using
low-volume jet injection for intradermal delivery the goal
is contain the delivery solution within the epidermis and
dermis but optimize gene expression levels. Conditions
for optimal gene expression were established by testing lu-
ciferase activity in the skin 48 h following injection of
pHCMVIE1-luciferase. Four rapid injections at each vol-
ume were used for total DNA delivery of 20 µl /20 µg plas-
mid DNA, 24 µl/24 µg plasmid DNA, and 28 µl/28 µg
plasmid DNA. The injected fluid remained within the der-
mis under all conditions. The delivery volume with the
highest mean luciferase expression was chosen as the op-
timal delivery condition for the immunization studies.
This optimal setting of 28 µl/28 µg plasmid DNA deliv-
ered at 3-Bar was utilized for each immunization time
point.
A Helios Gene Gun System, (Bio-Rad Laboratories, Her-
cules, CA) was utilized for particle bombardment. Plas-
mid DNA was precipitated onto gold particles 1.6 microns
in diameter following standard protocols [21]. Optimiza-
tion conditions tested included the helium pressure, con-
centration of polyvinylpyrrolidone (PVP), amount of
carrier gold and DNA concentration as described previ-
ously [23]. Conditions for optimal gene expression were
established by testing luciferase activity in the skin 48 h
following injection of pHCMVIE1-luciferase. The set of
conditions (pressure/PVP concentration/gold and DNA
amounts) with the highest mean luciferase expression and
optimal skin penetration was chosen as the optimal com-
bination for immunization studies. This optimal setting
of one µg plasmid DNA prepared with 0.05 mg/ml PVP/
0.50 mg gold delivered at 360 psi was utilized for each im-
munization time point.
A plasmid DNA solution at 1 µg/µl was prepared in PBS.
A 29-gauge needle and 1 ml syringe were utilized for intra-
dermal injection. Conditions for optimal gene expression
in the injected skin were established prior to the genetic
immunization experiments. When using needle and sy-
ringe injection for intradermal delivery the goal is contain
the delivery solution within the epidermis and dermis but
optimize gene expression levels. Conditions for optimal
gene expression were established by testing luciferase ac-
tivity in the skin 48 h following injection of pHCMVIE1-
luciferase. A maximum of 20 µl/20 µg plasmid DNA could
be injected and kept contained within the epidermis and
dermis. This volume yielded the highest luciferase values.
The optimal condition of twenty µl (20 µg plasmid DNA)
was delivered at each immunization time point.
Luciferase Assay
Two days after injection rabbits were euthanized and the
area of injected skin excised. Skin tissue was homogenized
in lysis reagent buffer (Luciferase Assay System, Promega,
Madison, WI). For each injection sample, luciferase activ-
ity was measured in duplicate using a TD-20/20 Lumi-
nometer (Turner Designs, Sunnyvale, CA) [2].
Enzyme-linked immunosorbent assay (ELISA)
Affinity-purified recombinant Hepatitis B antigen pro-
duced in Saccharomyces cerevisae following transforma-
tion with the plasmid pCGA7 was used for detection of
antibody responses using an ELISA (Aldevron, Fargo, ND)
[20]. The recombinant antigens were diluted in 0.1 M car-
bonate buffer (pH 9.6) and coated at 1 ug/100 ul per well
in 96-well microtitre plates (Dynex Technologies, INC.
Chantilly, VA). Adjoining negative control wells were
coated with 0.1 M carbonate buffer (pH 9.6) alone. The
plates were incubated at 4°C overnight. Plates were
washed three times in phosphate buffered saline (PBS)
(pH 7.4) and blocked with 5% bovine serum albumin
(BSA) in PBS before serum was added. One hundred ul of
PBS-Tween-20 with 1% BSA was added to each well. To
quantify the antibody response at the different time
points after injection(s) for each rabbit, 100 ul of diluted
serum samples at 1:25, 1:250 and 1:2,500 were added to
separate wells in duplicate. Assays for all time points were
performed simultaneously. The entire assay was repeated
at least twice for all samples. Rabbit sera obtained prior to
any injection were utilized as negative controls. The plate
was incubated at 37°C for 1 h. After additional washing,
phosphatase-conjugated goat anti-rabbit IgG antibody
was added into each sample well and incubated for 1 h at
37°C. Diethanolamine (DEA) buffer phosphatase sub-
strate (Kirkegaard Perry Lab, Gaithersburg, Maryland) was
added into all wells and the plates were incubated for 30
min at room temperature in the dark. The reaction was ter-
minated after the appearance of color using 3 N NaOH.
The absorbance was measured at 410 nm using a micro-
plate reader (Emax, Sunnyvale, CA). The mean value for
each set of duplicate wells was determined. Specific bind-
ing to the Hepatitis B antigen was determined by subtract-
ing the mean value from the negative control wells that
were coated with buffer alone from the mean value from
the Hepatitis B-coated experimental wells. Rabbits de-
fined as demonstrating an immune response exhibited a
statistically significantly higher mean absorbance reading
following injection measured at serum dilutions of 1:250
and 1:2,500 at a minimum of two serial time points fol-
lowing injection as compared to mean values for negative
control serum.
Statistical analysis
Means and standard errors (S.E.) for the luciferase expres-
sion assays and antibody responses as measured by ELISABMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/10
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were calculated (SPSS 9.0, SPSS, Inc., Chicago, IL). Mean
antibody responses were compared by ANOVA (SPSS
9.0). P ≤  0.05 was considered a statistically significant dif-
ference.
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